Saint Germain-en-Laye, France

Michel Brahic



 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michel Brahic: Innovator in Measles Virus Research

Introduction

Michel Brahic is a notable inventor based in Saint Germain-en-Laye, France. He has made significant contributions to the field of virology, particularly in the development of immunogenic compositions related to the measles virus. With a total of 3 patents, his work has had a considerable impact on vaccine research.

Latest Patents

Among his latest patents is the invention titled "Infectious cDNA of an approved vaccine strain of measles virus, use for immunogenic compositions." This invention relates to a cDNA molecule that encodes the nucleotide sequence of the full-length antigenomic (+)RNA strand of a measles virus originating from an approved vaccine strain. It also concerns the preparation of immunogenic compositions using this cDNA. This innovative approach aims to enhance the efficacy of vaccines against measles.

Career Highlights

Michel Brahic has worked with prestigious institutions such as Institut Pasteur and the Centre National de la Recherche Scientifique. His career has been marked by a commitment to advancing scientific knowledge and improving public health through innovative research.

Collaborations

Throughout his career, Michel has collaborated with esteemed colleagues, including Chantal Combredet and Valérie Labrousse-Najburg. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Michel Brahic's contributions to the field of virology, particularly in the development of measles virus immunogenic compositions, highlight his role as an influential inventor. His work continues to pave the way for advancements in vaccine research and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…